Abstract
Advanced vulvar cancer is associated with a very poor prognosis. Surgical resection is the mainstay of treatment, with radiation indicated for areas at high risk for recurrence. When surgical and radiation options have been exhausted, the effectiveness of systemic chemotherapy is poor. No biologic or targeted agents have been approved for the management of advanced or recurrent vulvar cancer. Pembrolizumab, a humanized monoclonal antibody against programmed death 1 (PD-1), has been successfully used as a target of tumor immune therapy in small cell lung cancer and melanoma. We present the first case in the literature of a patient with recurrent vulvar cancer who was treated successfully with pembrolizumab. Caris next-generation testing revealed a PD-L1 and PD-1 mutation (PD-L1 positive, 2+, 100%). She attained a complete clinical remission after 2 cycles, and a CT scan after 6 cycles revealed a significant response by RECIST criteria. After completing 10 cycles, treatment was stopped due to complications of severe malnutrition related to narcotic abuse. A CT scan 10 weeks after the final treatment revealed no adenopathy. Pembrolizumab is a safe and effective chemotherapeutic agent to treat recurrent vulvar carcinoma.
Citations
Dec 31, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christoph Wohlmuth, Iris Wohlmuth-Wieser
Dec 13, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christoph Wohlmuth, Iris Wohlmuth-Wieser
Sep 5, 2019·Journal for Immunotherapy of Cancer·Kim E KortekaasSjoerd H van der Burg
Dec 12, 2019·Archives of Gynecology and Obstetrics·Anna JaegerLinn Woelber
May 24, 2020·International Journal of Cancer. Journal International Du Cancer·Andreas StangLaura Khil
Jun 5, 2020·The American Journal of Surgical Pathology·Megan E DibbernAnne M Mills
Dec 18, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sofia LériasAna Félix
Apr 27, 2020·Journal of Cancer Research and Clinical Oncology· Giulia MantovaniGiorgia Garganese
Feb 7, 2020·Journal of Cancer Research and Clinical Oncology·Bastian CzogallaElisa Schmoeckel
Mar 7, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jacob CurleyAnne M Mills
Dec 9, 2020·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Anne M Mills
Feb 13, 2021·Scientific Reports·Jeffrey A HowAung Naing
Dec 31, 2020·International Journal of Molecular Sciences·Fulvio BorellaLeonardo Micheletti
Sep 29, 2020·Gynecologic Oncology Reports·Madison R KlavansSusan C Modesitt
Dec 15, 2020·Oncology Research·Linn WoelberAnna Jaeger
Jun 15, 2021·Frontiers in Oncology·Yuhan WangTingting Yao
Jul 3, 2021·Future Oncology·Tarek AssiFadi Farhat
Oct 31, 2021·Journal for Immunotherapy of Cancer·Kim E KortekaasSjoerd H van der Burg
Sep 9, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anne M MillsKari L Ring